Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 215.85M | 237.88M | 255.21M | 272.94M | 274.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 215.85M | 237.88M | 255.21M | 272.94M | 274.61M |
| Cost of Revenue | 153.02M | 151.98M | 151.19M | 148.85M | 148.71M |
| Gross Profit | 62.83M | 85.90M | 104.02M | 124.09M | 125.90M |
| SG&A Expenses | 158.47M | 160.45M | 161.77M | 154.91M | 154.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 330.17M | 331.14M | 331.82M | 322.65M | 322.29M |
| Operating Income | -114.32M | -93.27M | -76.61M | -49.71M | -47.68M |
| Income Before Tax | -348.96M | -295.69M | -265.41M | 437.28M | 592.36M |
| Income Tax Expenses | -3.82M | -1.97M | -1.86M | 764.32M | 758.54M |
| Earnings from Continuing Operations | -345.14 | -293.72 | -263.55 | -327.04 | -166.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 150.42M | 128.81M | 116.50M | 100.17M | 31.90M |
| Net Income | -194.72M | -164.92M | -147.05M | -226.86M | -134.29M |
| EBIT | -114.32M | -93.27M | -76.61M | -49.71M | -47.68M |
| EBITDA | -64.13M | -43.81M | -28.23M | -2.89M | -1.86M |
| EPS Basic | -1.37 | -1.16 | -1.05 | -1.66 | -1.01 |
| Normalized Basic EPS | 0.46 | 0.40 | 0.38 | 3.55 | 3.08 |
| EPS Diluted | -1.37 | -1.17 | -1.05 | -1.67 | -1.02 |
| Normalized Diluted EPS | 0.46 | 0.40 | 0.38 | 3.55 | 3.08 |
| Average Basic Shares Outstanding | 571.03M | 562.63M | 551.54M | 541.87M | 532.25M |
| Average Diluted Shares Outstanding | 571.03M | 562.63M | 551.54M | 541.87M | 532.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |